Uxin (UXIN) EBIT (2017 - 2026)

Uxin (UXIN) has reported EBIT for 10 consecutive years, with -$9.6 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, EBIT fell 97.9% year-over-year to -$9.6 million; the trailing twelve-month figure through Mar 2026 stood at -$29.1 million (up 32.19% YoY), and the FY2025 full-year result was -$24.2 million, up 38.0% from the prior year.
• EBIT retreated to -$9.6 million in Q1 2026 per UXIN's latest filing, from -$8.4 million in the prior quarter.
• Across five years, EBIT topped out at -$4.9 million in Q1 2025 and bottomed at -$23.9 million in Q4 2024.
• Historically, EBIT has averaged -$11.1 million across 5 years, with a median of -$9.6 million in 2026.
• The sharpest annual moves came in 2022 and 2025: EBIT slumped 183.85% in 2022, then surged 68.07% in 2025.
• Over 5 years, EBIT stood at -$14.0 million in 2022, then grew by 26.46% to -$10.3 million in 2023, then plunged by 132.25% to -$23.9 million in 2024, then jumped by 64.88% to -$8.4 million in 2025, then dropped by 14.51% to -$9.6 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered -$9.6 million, -$8.4 million, and -$5.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.